# Preventive Therapy for Tuberculosis in HIV Infected Persons

> **NCT00351702** · PHASE3 · COMPLETED · sponsor: **Tuberculosis Research Centre, India** · enrollment: 683 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Tuberculosis

## Interventions

- **DRUG:** Isoniazid with Ethambutol

## Key facts

- **NCT ID:** NCT00351702
- **Lead sponsor:** Tuberculosis Research Centre, India
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2008-09
- **Final completion:** 2011-06
- **Target enrollment:** 683 (ACTUAL)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351702, "Preventive Therapy for Tuberculosis in HIV Infected Persons". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00351702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*